Diltia Xt
NDC Package 62037-548-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Diltia Xt is a . Marketed by Actavis Pharma, Inc., this product is identified by NDC 62037-548 and is authorized under FDA application ANDA074852.

Identification & Billing

NDC Package Code
62037-548-01
Package Description
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
62037054801
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Diltia Xt
Dosage Form
-

Regulatory & Marketing

Labeler Name
Actavis Pharma, Inc.
FDA Application #
ANDA074852
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-10-1997
End Marketing Date
05-22-2014
Listing Expiration
05-22-2014
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (62037-548). Click a package code to view its specific billing and regulatory data.

500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62037-548-01 identifies a specific commercial package of 100 capsule, extended release in 1 bottle, plastic of Diltia Xt, labeled by Actavis Pharma, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Actavis Pharma, Inc. on October 10, 1997. The current certification is valid through May 22, 2014.

How is this Actavis Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62037054801. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62037-548-01
11-Digit CMS (5-4-2)
62037-0548-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.